FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

126112002: Medroxyprogesterone acetate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
12706017 Medroxyprogesterone acetate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
730033018 Medroxyprogesterone acetate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2637791000005119 Medroxyprogesteronacetat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Medroxyprogesterone acetate Is a Medroxyprogesterone false Inferred relationship Some
Medroxyprogesterone acetate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Progestational hormone false Inferred relationship Some
Medroxyprogesterone acetate Is a Drug allergen false Inferred relationship Some
Medroxyprogesterone acetate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Medroxyprogesterone true Inferred relationship Some
Medroxyprogesterone acetate Is a Synthetic progestogen (substance) true Inferred relationship Some
Medroxyprogesterone acetate Is a Steroid hormone true Inferred relationship Some
Medroxyprogesterone acetate Is a Pregnane (substance) true Inferred relationship Some
Medroxyprogesterone acetate Is a Progestationelt hormon false Inferred relationship Some
Medroxyprogesterone acetate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Progesterone receptor agonist (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
medroxyprogesteronacetatpræparat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
Medroxyprogest ac [endocrine] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
Medroxyprogesterone acetate 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
Medroxyprogesterone acetate 2.5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
Medroxyprogesterone acetate 5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
Medroxyprogest acetate [progestogen oral contraceptive] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
medroxyprogesteronacetat 150 mg/ml injektionsvæske, suspension i fyldt injektionssprøjte a 1 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
Medroxyprogest ac [malignancy] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
Medroxyprogesterone acetate 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
Medroxyprogesterone acetate 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
medroxyprogesteronacetat 200 mg/ml injektionsvæske, suspension, hætteglas a 2,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
Medroxyprogesterone acetate 100 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
Medroxyprogesterone acetate 200 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
Medroxyprogesterone acetate 400 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
Medroxyprogesterone acetate 400mg/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
Medroxyprogesterone acetate 150mg/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
Medroxyprogesterone acetate 10mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
estradiolcypionat 5 mg + medroxyprogesteronacetat 25 mg injektionsvæske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
medroxyprogesteronacetat 400 mg/ml injektionsvæske, suspension, hætteglas a 2 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
medroxyprogesteronacetat 150 mg/ml injektionsvæske, suspension, hætteglas a 1 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
medroxyprogesteronacetat 400 mg/ml injektionsvæske, suspension, hætteglas a 2,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
medroxyprogesteronacetat 400 mg/ml injektionsvæske, suspension, hætteglas a 10 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
medroxyprogesteronacetat + estradiolcypionat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
medroxyprogesteronacetat 104 mg injektionsvæske, suspension i fyldt injektionssprøjte a 0,65 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
estradiol + medroxyprogesteron The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
Injection of medroxyprogesterone acetate (procedure) Direct substance True Medroxyprogesterone acetate Inferred relationship Some 1
Product containing estradiol cypionate and medroxyprogesterone acetate in parenteral dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
Product containing medroxyprogesterone acetate in parenteral dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
Product containing medroxyprogesterone acetate in oral dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some
Medroxyprogesterone acetate 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some 1
Medroxyprogesterone acetate 10 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Medroxyprogesterone acetate Inferred relationship Some 1
Medroxyprogesterone acetate 2.5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some 1
Medroxyprogesterone acetate 2.5 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Medroxyprogesterone acetate Inferred relationship Some 1
Medroxyprogesterone acetate 5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some 1
Medroxyprogesterone acetate 5 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Medroxyprogesterone acetate Inferred relationship Some 1
Medroxyprogesterone acetate 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some 1
Medroxyprogesterone acetate 250 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Medroxyprogesterone acetate Inferred relationship Some 1
Medroxyprogesterone acetate 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some 1
Medroxyprogesterone acetate 500 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Medroxyprogesterone acetate Inferred relationship Some 1
Medroxyprogesterone acetate 100 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some 1
Medroxyprogesterone acetate 100 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Medroxyprogesterone acetate Inferred relationship Some 1
Medroxyprogesterone acetate 200 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some 1
Medroxyprogesterone acetate 200 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Medroxyprogesterone acetate Inferred relationship Some 1
Medroxyprogesterone acetate 400 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Medroxyprogesterone acetate Inferred relationship Some 1
Medroxyprogesterone acetate 400 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Medroxyprogesterone acetate Inferred relationship Some 1
Medroxyprogesterone acetate 500 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Medroxyprogesterone acetate Inferred relationship Some 1
Medroxyprogesterone acetate 2.5 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Medroxyprogesterone acetate Inferred relationship Some 1
Medroxyprogesterone acetate 100 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Medroxyprogesterone acetate Inferred relationship Some 1
Medroxyprogesterone acetate 200 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Medroxyprogesterone acetate Inferred relationship Some 1
Medroxyprogesterone acetate 400 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Medroxyprogesterone acetate Inferred relationship Some 1
Medroxyprogesterone acetate 5 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Medroxyprogesterone acetate Inferred relationship Some 1
Medroxyprogesterone acetate 10 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Medroxyprogesterone acetate Inferred relationship Some 1
Medroxyprogesterone acetate 250 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Medroxyprogesterone acetate Inferred relationship Some 1
Product containing precisely medroxyprogesterone acetate 150 milligram/1 milliliter conventional release suspension for injection syringe This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Medroxyprogesterone acetate Inferred relationship Some 1
Product containing precisely medroxyprogesterone acetate 150 milligram/1 milliliter conventional release suspension for injection syringe The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Medroxyprogesterone acetate Inferred relationship Some 1
Product containing precisely medroxyprogesterone acetate 150 milligram/1 milliliter conventional release suspension for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Medroxyprogesterone acetate Inferred relationship Some 1
Product containing precisely medroxyprogesterone acetate 150 milligram/1 milliliter conventional release suspension for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Medroxyprogesterone acetate Inferred relationship Some 1
Product containing precisely medroxyprogesterone acetate 500 milligram/2.5 milliliter conventional release suspension for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Medroxyprogesterone acetate Inferred relationship Some 1
Product containing precisely medroxyprogesterone acetate 500 milligram/2.5 milliliter conventional release suspension for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Medroxyprogesterone acetate Inferred relationship Some 1
Product containing precisely medroxyprogesterone acetate 150 milligram/1 milliliter conventional release suspension for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Medroxyprogesterone acetate Inferred relationship Some 1
Product containing precisely medroxyprogesterone acetate 150 milligram/1 milliliter conventional release suspension for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Medroxyprogesterone acetate Inferred relationship Some 1
Medroxyprogesterone acetate 200 mg/mL suspension for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Medroxyprogesterone acetate Inferred relationship Some 1
Medroxyprogesterone acetate 200 mg/mL suspension for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Medroxyprogesterone acetate Inferred relationship Some 1
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Medroxyprogesterone acetate Inferred relationship Some 2
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Medroxyprogesterone acetate Inferred relationship Some 2
Medroxyprogesterone acetate 160 mg/mL suspension for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Medroxyprogesterone acetate Inferred relationship Some 1
Medroxyprogesterone acetate 160 mg/mL suspension for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Medroxyprogesterone acetate Inferred relationship Some 1
Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Medroxyprogesterone acetate Inferred relationship Some 3
Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Medroxyprogesterone acetate Inferred relationship Some 3
Estradiol valerate 2 mg and medroxyprogesterone acetate 20 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Medroxyprogesterone acetate Inferred relationship Some 1
Estradiol valerate 2 mg and medroxyprogesterone acetate 20 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Medroxyprogesterone acetate Inferred relationship Some 1
Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone acetate 1.5 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Medroxyprogesterone acetate Inferred relationship Some 2
Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone acetate 1.5 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Medroxyprogesterone acetate Inferred relationship Some 2
Product containing precisely conjugated estrogen 450 microgram and medroxyprogesterone acetate 1.5 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Medroxyprogesterone acetate Inferred relationship Some 2
Product containing precisely conjugated estrogen 450 microgram and medroxyprogesterone acetate 1.5 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Medroxyprogesterone acetate Inferred relationship Some 2
Conjugated estrogen 625 microgram and medroxyprogesterone acetate 2.5 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Medroxyprogesterone acetate Inferred relationship Some 2
Conjugated estrogen 625 microgram and medroxyprogesterone acetate 2.5 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Medroxyprogesterone acetate Inferred relationship Some 2
Estradiol cypionate 10 mg/mL and medroxyprogesterone acetate 50 mg/mL prolonged-release suspension for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Medroxyprogesterone acetate Inferred relationship Some 2
Estradiol cypionate 10 mg/mL and medroxyprogesterone acetate 50 mg/mL prolonged-release suspension for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Medroxyprogesterone acetate Inferred relationship Some 2

This concept is not in any reference sets

Back to Start